No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Perspective Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Express News | Perspective Therapeutics Inc: Jonathan Hunt Will No Longer Serve as CFO but Will Continue Serving as Co's Chief Accounting Officer
Perspective Therapeutics Appoints Juan Graham, MBA as Chief Financial Officer
Perspective Therapeutics to Participate in Upcoming Investor Conferences in December
Perspective Therapeutics Downgraded to Neutral From Buy at BofA
Perspective Therapeutics Is Maintained at Outperform by RBC Capital